E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma-Reference-Cited by-同舟云学术

E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma

Published:1979-12 Issue:12 Volume:15 Page:1511-1513
ISSN:0014-2964
Container-title:European Journal of Cancer (1965)
language:en
Short-container-title:European Journal of Cancer (1965)

Author:

Bramwell Vivien H.C.,Brugarolas A.,Mouridsen H.T.,Cheix Françoise,De Jager R.,Van Oosterom A.T.,Vendrik C.P.,Pinedo H.M.,Sylvester R.,De Pauw Marlene

Publisher

Elsevier BV

Subject

General Medicine

Reference15 articles.

1. Cis-diammine-dichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer;Einhorn;Ann. intern. Med.,1977

2. Phase II study of cis-dichlorodiammineplatium (II) (NSC-119875) in advanced adenocarcinoma of the ovary;Wiltshaw;Cancer Treat. Rep.,1976

3. Cis-dichlorodiammineplatinum (II) in advanced bladder cancer;Yagoda;Cancer Treat. Rep.,1976

4. Cis-dichlorodiammineplatinum (II) in advanced osteogenic sarcoma;Ochs;Cancer Treat. Rep.,1978

5. E. Baum, P. Gaynon, L. Greenberg, W. Krivit and D. Hammond, Cis-platinum diammine dichloride—phase II study in osteogenic sarcoma of childhood. Cancer Treat Rep. (In press).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-induced hearing loss after treatment for childhood cancer;Cochrane Database of Systematic Reviews;2016-08-03

2. Mapping the literature: Role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma;Drugs of Today;2009

3. Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone;International Journal of Gynecological Cancer;2004-11

4. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas;International Journal of Gynecological Cancer;2002-11

5. Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts;British Journal of Cancer;1994-07